Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 20 850 KRW Market Closed
Market Cap: 306.7B KRW
Have any thoughts about
Korea United Pharm Inc?
Write Note

Relative Value

The Relative Value of one Korea United Pharm Inc stock under the Base Case scenario is 31 176.25 KRW. Compared to the current market price of 20 850 KRW, Korea United Pharm Inc is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
31 176.25 KRW
Undervaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
65
Median 3Y
1.3
Median 5Y
1.4
Industry
2.6
Forward
1
vs History
44
vs Industry
40
Median 3Y
8.7
Median 5Y
9.1
Industry
22.3
Forward
5.2
vs History
85
vs Industry
44
Median 3Y
6.5
Median 5Y
7.2
Industry
17.5
vs History
vs Industry
27
Median 3Y
12.2
Median 5Y
13.2
Industry
24.8
vs History
96
vs Industry
65
Median 3Y
1
Median 5Y
1.1
Industry
2.1
vs History
96
vs Industry
77
Median 3Y
0.9
Median 5Y
1
Industry
2.7
Forward
0.6
vs History
96
vs Industry
78
Median 3Y
1.6
Median 5Y
1.8
Industry
5.3
vs History
96
vs Industry
48
Median 3Y
4
Median 5Y
5.3
Industry
13.4
Forward
2.5
vs History
96
vs Industry
45
Median 3Y
4.7
Median 5Y
6.3
Industry
16.8
Forward
2.9
vs History
92
vs Industry
47
Median 3Y
4.4
Median 5Y
5.6
Industry
15.9
vs History
73
vs Industry
33
Median 3Y
9.3
Median 5Y
11.7
Industry
18.5
vs History
96
vs Industry
68
Median 3Y
0.8
Median 5Y
0.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Korea United Pharm Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Korea United Pharm Inc
KRX:033270
306.7B KRW 1.1 9.5 2.8 3.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
793.7B USD 20.4 108.1 54.1 60.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.1 37.5 25 28.7
US
Johnson & Johnson
NYSE:JNJ
385.5B USD 4.4 26.3 12.7 16.5
US
Merck & Co Inc
NYSE:MRK
260.6B USD 4.2 19 12.9 15.8
CH
Roche Holding AG
SIX:ROG
213.6B CHF 3.6 18.6 10.4 12.4
UK
AstraZeneca PLC
LSE:AZN
171.2B GBP 4.5 34.5 170.6 255.7
CH
Novartis AG
SIX:NOVN
183.5B CHF 4.3 13.1 10.4 15.4
US
Pfizer Inc
NYSE:PFE
161.4B USD 2.7 38 11.1 16.7

See Also

Discover More
Back to Top